These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 16268266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
    Sticherling M, Franke A, Aberer E, Gläser R, Hertl M, Pfeiffer C, Rzany B, Schneider S, Shimanovich I, Werfel T, Wilczek A, Zillikens D, Schmidt E.
    Br J Dermatol; 2017 Nov; 177(5):1299-1305. PubMed ID: 28494097
    [Abstract] [Full Text] [Related]

  • 5. Whole body application of a potent topical corticosteroid for bullous pemphigoid.
    Terra JB, Potze WJ, Jonkman MF.
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654
    [Abstract] [Full Text] [Related]

  • 6. [Bullous pemphigoid: a review].
    Bernard P, Charneux J.
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A, Kowalczyk E, Jagielski P, Kowalewski C, Wozniak K.
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prediction of survival for patients with bullous pemphigoid: a prospective study.
    Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC.
    Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
    [Abstract] [Full Text] [Related]

  • 15. Treatment of bullous pemphigoid.
    Fontaine J, Joly P, Roujeau JC.
    J Dermatol; 2003 Feb; 30(2):83-90. PubMed ID: 12692373
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
    Boughrara Z, Ingen-Housz-Oro S, Legrand P, Duong TA, Roujeau JC.
    Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
    [Abstract] [Full Text] [Related]

  • 18. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid.
    Arash A, Shirin L.
    J Oral Pathol Med; 2008 Jul; 37(6):341-4. PubMed ID: 18331284
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P, Eriksson H, Berg P.
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.